VEGFA and metastatic colorectal cancer: Combinations of cytotoxic agents including fluoropyrimidine (FP), oxaliplatin and/or irinotecan in combination with either anti-VEGF or, for RAS WT tumors, anti-EGFR antibodies represent the current standard of first-line treatment for patients with metastatic colorectal cancer (mCRC) [3].